Companies › NRXS
NEURAXIS INC (NRXS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001933567 · EDGAR filings · Updated 2026-07-23
NEURAXIS INC (NRXS) has reported institutional ownership of 18.2%, with 26 institutional managers holding positions valued at $14.7M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-23 — Shelf registration (S-3) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-10 — Employee-plan registration (S-8) filed
- 2026-07-10 — Current report (8-K) filed
- 2026-06-12 — Current report (8-K) filed
- 2026-05-12 — Quarterly report (10-Q) filed
- 2026-05-01 — SCHEDULE 13G/A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, NEURAXIS INC has 26 institutional holders and institutional ownership of 18.2%.
Insider activity
Insiders reported 15 transactions (5 buys, 2 sells) across 6 reporting insiders, with a net reported value of $373.3K.
Data flags from SEC filings
Related companies
Hyperfine Inc (HYPR) · FORTRESS BIOTECH INC (FBIO) · REIN THERAPEUTICS INC (RNTX) · PARK DENTAL PARTNERS INC (PARK) · MOLECULAR PARTNERS AG (MOLN) · QT IMAGING HLDGS INC (QTI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.